AskNiveshWeekend·19:11 IST
  • Stocks
  • ·
  • Funds
  • ·
  • Signals

AskNivesh is a research desk for Indian markets, US equities, fund data, and disclosure trails. Built for investors who want source-backed context without the noise.

Market

  • Overview
  • Stocks
  • Indexes
  • Sectors
  • ETFs
  • Funds
  • IPOs

US Market

  • Political Trades
  • Disclosure Leaderboard
  • Politicians
  • Consensus Trades
  • Late Disclosures
  • Sector Tilt
  • US Stocks

Market Pulse

  • Market Pulse
  • Global Markets
  • Signals
  • FII DII Activity
  • Corporate Actions
  • RBI Macro
  • Derivatives
  • Currency Derivatives
  • Index Derivatives
  • Commodity Derivatives
  • F&O Expiries

Data

  • Glossary
  • Methodology
  • Analysis Methods
  • Technical Analysis
  • Candle Patterns
  • Brokers
  • Depositories
  • SEBI Intermediaries
  • Exchange Holidays
  • Global Investing
  • Sitemap

Company

  • About Us
  • Contact

Legal

  • Terms and Conditions
  • Privacy Policy
  • Disclaimer
  • Methodology
  • ·Glossary
  • ·Sitemap
  • ·Contact
Browse stocks by letter
AllABCDEFGHIJKLMNOPQRSTUVWXYZOthers

Research and education only. Not investment advice under SEBI (IA) Regulations 2013, not a research report under SEBI (RA) Regulations 2014. Not a SEBI-registered Adviser, Analyst, or distributor.

AskNivesh©2026
asknivesh.com
← Back to EMCURE

Emcure Pharmaceuticals Ltd.: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

ParticularsMar-25Jun-25Sep-25Dec-25Mar-26
Revenue
2,1162,1012,2702,3632,470
Other income
54324
Expenses
1,8501,8101,9322,0132,143
Cost of materials consumed
404432420421419
Purchases of stock-in-trade
572550625560661
Change in inventories
-84-181-156-19-77
Employee benefit expense
373393385387387
Finance costs
3927333846
Depreciation & amortisation
97100105105106
Other expenses
448488520521600
EBITDA
397417479457493
EBIT
300318374352387
Exceptional items
-10-4--3810
Profit Before Tax
261291341314341
Tax expense
6376908297
Deferred tax
-28-10-3-20-14
Net Profit
197215251231244
Financial Ratios
Operating Profit Margin
14.18%15.13%16.45%14.90%15.68%
EBITDA Margin
18.75%19.86%21.08%19.34%19.98%
Net Profit Margin
9.31%10.23%11.06%9.78%9.88%
Earnings Per Share (₹)
9.9710.9212.8512.1612.84

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.